Pfizer's exploratory talks with Shanghai Pharma a portent of deals to come
This article was originally published in Scrip
Executive Summary
Pfizer has begun to explore what could become a significant broadening of its relationship with one of China's largest pharma groups, entering into a memorandum of understanding with Shanghai Pharmaceutical to "jointly pursue potential business opportunities in China."